References
- Greene CM, Marciniak SJ, Teckman J, et al. α1-antitrypsin deficiency. Nat Rev Dis Primers. 2016;2(1):1. Jul 28 Erratum in: nat Rev Dis Primers. 2018 Oct 29;4(1):40. PMID: 27465791. doi:10.1038/nrdp.2016.51.
- Hatipoğlu U, Stoller JK. α1-antitrypsin deficiency. Clin Chest Med. 2016; Sep37(3):487–3. Epub 2016 Jun 25. PMID: 27514595. doi:10.1016/j.ccm.2016.04.011.
- Fishbein AB, Silverberg JI, Wilson EJ, et al. Update on atopic dermatitis: diagnosis, severity assessment, and treatment selection. J Allergy Clin Immunol Pract. 2020;8(1):91–101. Jan Epub 2019 Aug 29. PMID: 31474543; PMCID: PMC7395647. doi:10.1016/j.jaip.2019.06.044.
- Brar KK, Nicol NH, Boguniewicz M. Strategies for successful management of severe atopic dermatitis. J Allergy Clin Immunol Pract. 2019; Jan7(1):1–16. PMID: 30598172. doi:10.1016/j.jaip.2018.10.021.
- Adam DN, Gooderham MJ, Beecker JR, et al. Expert consensus on the systemic treatment of atopic dermatitis in special populations. J Eur Acad Dermatol Venereol. 2023;37(6):1135–1148. Jun doi:10.1111/jdv.18922.
- Jia F, Zhao Q, Shi P, et al. Dupilumab: advances in the off-label usage of IL4/IL13 antagonist in dermatoses. Dermatol Ther. 2022;35(12):e15924. Dec doi:10.1111/dth.15924.
- Martín-González E, Hernández-Pérez JM, Pérez JAP, et al. Alpha-1 antitrypsin deficiency and Pi*S and Pi*Z SERPINA1 variants are associated with asthma exacerbations. Pulmonology. 2023;24:s2531-0437(23)00091-0. doi:10.1016/j.pulmoe.2023.05.002.
- Aiello M, Frizzelli A, Pisi R, et al. Alpha-1 antitrypsin deficiency is significantly associated with atopy in asthmatic patients. J Asthma. 2022;59(1):23–30. doi:10.1080/02770903.2020.1827421.
- Eden E. Asthma and COPD in alpha-1 antitrypsin deficiency. Evidence for the dutch hypothesis. COPD. 2010; Oct7(5):366–374. doi:10.3109/15412555.2010.510159.
- Stirpe E, Bardaro F. Alpha1-antitrypsin deficiency and asthma. Monaldi Arch Chest Dis. 2022;92(4). doi:10.4081/monaldi.2022.2179.